Introduction of HIV into drug injector networks outside AIDS epicentres

被引:12
作者
Williams, ML [1 ]
Zhao, ZX [1 ]
Bowen, AM [1 ]
Freeman, RC [1 ]
Elwood, WN [1 ]
Rusek, R [1 ]
机构
[1] NOVA RES CO, BETHESDA, MD USA
关键词
HIV infection; drug use; sexual risk; low seroprevalence area; drug user network;
D O I
10.1258/0956462971918896
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Injection drug users (IDUs) continue to be at risk for HIV infection despite high levels of knowledge about how human immunodeficiency virus/ acquired immunodeficiency syndrome (HIV/AIDS) is transmitted. Yet, among not-in-treatment injection drug users, the chances of becoming infected with HIV vary substantially. Information regarding the factors that facilitate the introduction of HIV into networks of drug injectors in low HIV seroprevalence cities is urgently needed. This study examines the factors related to HIV seroprevalence in a large (n=9492), multi-site sample of IDUs recruited in 11 low seroprevalence cities. Univariate and multivariate associations between drug injection and sexual behaviours and travel to an AIDS epicentre were examined. Results show that, next to male-to-male sexual contact, having sex at least twice in an AIDS epicentre was the strongest predictor of HIV infection. Also associated with higher odds of being HIV-positive were racial/ethnic characteristics, daily drug injection, and injecting drugs in an AIDS epicentre. These results confirm that travelling to an AIDS epicentre and having sex or injecting drugs play a large role in the introduction of HIV into drug injector networks in low seroprevalence cities.
引用
收藏
页码:629 / 635
页数:7
相关论文
共 38 条
  • [1] BATTJES RJ, 1989, J ACQ IMMUN DEF SYND, V2, P533
  • [2] Bloor Michael, 1995, The Sociology of HIV Transmission
  • [3] BROWN B, 1993, HDB RISK AIDS INJECT, pR32
  • [4] AN ETHNOGRAPHIC APPROACH TO TARGETED SAMPLING - PROBLEMS AND SOLUTIONS IN AIDS-PREVENTION RESEARCH AMONG INJECTION-DRUG AND CRACK-COCAINE USERS
    CARLSON, RG
    WANG, JC
    SIEGAL, HA
    FALCK, RS
    GUO, J
    [J]. HUMAN ORGANIZATION, 1994, 53 (03) : 279 - 286
  • [5] *CDCP, 1988, MMWR-MORBID MORTAL W, V38, P156
  • [6] DESJARLAIS DC, 1992, BRIT J ADDICT, V87, P347
  • [7] MAINTAINING LOW HIV SEROPREVALENCE IN POPULATIONS OF INJECTING DRUG-USERS
    DESJARLAIS, DC
    HAGAN, H
    FRIEDMAN, SR
    FRIEDMANN, P
    GOLDBERG, D
    FRISCHER, M
    GREEN, S
    TUNVING, K
    LJUNGBERG, B
    WODAK, A
    ROSS, M
    PURCHASE, D
    MILLSON, ME
    MYERS, T
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (15): : 1226 - 1231
  • [8] RISK-FACTORS FOR HUMAN-IMMUNODEFICIENCY-VIRUS SEROCONVERSION AMONG OUT-OF-TREATMENT DRUG INJECTORS IN HIGH AND LOW SEROPREVALENCE CITIES
    FRIEDMAN, SR
    JOSE, B
    DEREN, S
    JARLAIS, DCD
    NEAIGUS, A
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1995, 142 (08) : 864 - 874
  • [9] REDUCTION IN NEEDLE SHARING AMONG COMMUNITY WIDE SAMPLES OF INJECTING DRUG-USERS
    FRISCHER, M
    BLOOR, M
    GREEN, S
    GOLDBERG, D
    COVELL, R
    MCKEGANEY, N
    TAYLOR, A
    [J]. INTERNATIONAL JOURNAL OF STD & AIDS, 1992, 3 (04) : 288 - 290
  • [10] GARDNER LI, 1989, J ACQ IMMUN DEF SYND, V2, P521